Furthermore, a recent cross-sectional study investigated intestinal barrier dysfunction in patients with PSC after liver transplantation by measuring the levels of Reg3a, iFABP, zonulin, and calprotectin. This evidence concerns the gene HP and pancreatic serous cystadenoma.